Arcutis Biotherapeutics: Behind The Big Rally

Arcutis Biotherapeutics surges on strong Q3 results, Zoryve growth, and a bullish FY 2026 outlook. Click here to find out why ...
European Medical Journal

Immunotherapeutic Strategies Based on CAR-T Cells in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...